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Summary
Kinesins in the mitotic spindle play major roles in deter-
mining spindle shape, size, and bipolarity, although specific
regulation of these kinesins at distinct locations on the
spindle is poorly understood. So that the forces that are
required for spindle bipolarity are balanced, microtubule-
depolymerizing kinesins are tightly regulated. Aurora B
kinase phosphorylates the neck regions of the kinesin-13
family microtubule depolymerases Kif2a and mitotic centro-
mere-associated kinesin (MCAK) and inhibits their depoly-
merase activities. How they are reactivated and how this is
controlled independently on different kinetochore fibers is
unknown. We show that inner centromere Kin-I stimulator
(ICIS), which stimulates the related depolymerase MCAK,
can reactivate Kif2a after Aurora B inhibition. When anti-
bodies that block the ability of ICIS to activate Kif2a are
injected into cells, monopolar spindles are generated. This
phenotype is rescued by coinjection of anti-Nuf2 antibodies.
We have performed a structure-function analysis of the ICIS
protein and find that the N terminus of ICIS binds Aurora B
and its regulators INCENP and TD60, whereas a central
region binds MCAK, Kif2a, and microtubules, suggesting
a scaffold function for ICIS. These data argue that ICIS and
the chromosomal passenger complex (CPC) regulate Kif2a
depolymerase activity.
Results and Discussion
The C Terminus of ICIS Reverses Aurora B Inhibition
of Kif2a In Vitro
The microtubule depolymerase activities of Kif2a and mitotic
centromere-associated kinesin (MCAK) are inhibited through
phosphorylation by Aurora kinases [1–3]. On MCAK, this phos-
phorylation event has been mapped to the neck region, which
lies proximal to the kinesin domain. Not only does Aurora regu-
late MCAK activity, but it also regulates its localization on the
spindle [1, 3, 4]. Surprisingly, phosphorylated MCAK is often
found at locations where MCAK activity is required [5, 6].
Therefore, there must be tight spatial regulation of the activity
of these proteins in their different subcellular locations, as well
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Aurora phosphorylation.
We adapted a system to measure Kif2a microtubule depoly-
merase activity in vitro [1]. Rhodamine-labeled taxol-stabilized
microtubules were incubated with recombinant Kif2a aa
118–530, which is the minimal domain required for depolymer-
ase activity (Kif2a minimal domain). Although this protein
construct was cloned from the human sequence, it is 93%
identical to the Xenopus sequence (Figure S1 available online).
Titration of Kif2a into the reaction shows concentration-
dependent depolymerase activity with linear responses and
saturation of activity after 40 nM (Figure 1A).
Because inner centromere Kin-I stimulator (ICIS) was shown
to regulate MCAK microtubule depolymerase activity in vitro,
we tested whether it could similarly regulate Kif2a. Four trun-
cation proteins were made from the full-length Xenopus ICIS
protein: ICIS A (ICIS1–334), B (ICIS334–724), C (ICIS724–992) and
D (ICIS992–1338) (Figure 1B). The C fragment contains the
protein’s F box, and the D fragment is the protein’s coiled-
coil domain. All proteins were expressed in E. coli as 6-His
fusion proteins and purified on Ni2+ columns. An amount of
50 nM Kif2a depolymerized most microtubules by 7 min (Fig-
ures 1C and Figure S2). Surprisingly, none of the ICIS frag-
ments could stimulate this activity (Figures 1C and S2 and
data not shown).
Phosphorylation of Kif2a by Aurora B for 15 min before the
addition of microtubules inhibited Kif2a depolymerase activity
(Figures 1C and S2). To test its effects on phosphorylated
Kif2a, we then added equimolar amounts of ICIS fragments
to the reactions after Aurora B phosphorylation, and depoly-
merase activity was measured. The ICIS D fragment (the
C-terminal, coiled-coil region) did not have an effect on Kif2a
alone, but it could restore Kif2a activity after it was first in-
hibited by Aurora B phosphorylation (Figure 1C). The other
fragments had no detectable effect on Kif2a activity (data
not shown). A titration of ICIS D into this reaction demonstrates
that Kif2a activity increases with ICIS D concentration, and
activity approaches that of unphosphorylated Kif2a at stoi-
chiometric amounts of ICIS D (Figure 1D). It appears that
Kif2a cannot be stimulated above the unphosphorylated
amount of activity because adding five or ten times stoichio-
metric amounts of ICIS did not activate Kif2a above its uninhib-
ited activity (Figure S3). These data suggest that ICIS binding
restores the activity of Kif2a that has been inhibited by Aurora
B phosphorylation.
ICIS could reactivate Kif2a by removing the inhibitory phos-
phorylation or by direct stimulation. Aurora B inhibits MCAK
activity by phosphorylation on serine 196 in the neck region
of the protein. We found an equivalent site in the neck region
of Kif2a, serine 132, and tested whether this site was phos-
phorylated by Aurora B (Figure S4A). Unfortunately, recombi-
nant Kif2a-S132A mutant protein has no depolymerase
activity, making it impossible to conclusively show that this
is the key inhibitory site on Kif2a. We made a polyclonal anti-
body against phospho-S132 of Kif2a. Antibody recognition of
Kif2a in vitro required prior phosphorylation by Aurora kinase,
demonstrating that this antibody is phosphospecific (Figures
1E and S4B). Moreover, the antibody recognizes a protein at
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inhibitors, which is the expected size of Xenopus Kif2a. To
determine whether ICIS is dephosphorylating Kif2a to reacti-
vate activity, we immunoblotted the recombinant microtubule
depolymerase reaction with the pS132 antibody (Figure 1E).
Phosphorylation of the presumptive inhibitory site did not
decrease when ICIS stimulates activity. These data argue
that ICIS D activates phosphorylated Kif2a not by dephos-
phorylation but by direct binding.
To characterize the interactions of ICIS D in vivo, we cova-
lently linked recombinant ICIS D to Sepharose beads. These
beads were incubated in mitotic Xenopus extracts, and asso-
ciated proteins were probed by immunoblot. As expected from
biochemical experiments, ICIS D binds MCAK and Kif2a
(Figure 1F). In addition, ICIS D bound Aurora B and its activa-
tors INCENP and TD-60. ICIS D beads were also incubated
with purified recombinant Kif2a, which showed that ICIS D
and Kif2a interact directly in vitro (Figure 1G).
These data argue for dual regulation of kinesin-13 microtu-
bule depolymerases. First, Aurora B kinase phosphorylates
the neck domain of these proteins to inhibit depolymerase
activity. Second, a coiled-coil domain on ICIS then reactivates
inhibited Kif2a. It is likely that MCAK is regulated in the same
way, even though ICIS has been demonstrated to stimulate
intrinsic MCAK depolymerase activity [7]. We contend that
the purified MCAK used in the original experiments contained
both inhibited and uninhibited protein. MCAK purified from ba-
culovirus (which was used in the original experiments) is phos-
phorylated on S196 and, thus, is partially inhibited (Figure S5).
MCAK from baculovirus is not fully phosphorylated, given that
we could more than double the pS196 staining after incubation
with Aurora B kinase (data not shown). Because we used re-
combinant Kif2a from bacteria (which is not phosphorylated),
it can only be activated by ICIS after Aurora B phosphorylation.
However, it is important to test this idea in the future because
another important difference between the two experiments is
that we used the catalytic portion of Kif2a, whereas previous
experiments were performed with full-length MCAK.
Anti-ICIS Injection Results in a Monopolar Spindle
Phenotype
To determine whether the C terminus of ICIS regulates kinesin-
13 s in vivo, we generated a polyclonal antibody against ICIS D
(Figure S6). After affinity purification, this antibody predomi-
nantly recognized a protein at the expected molecular weight
for ICIS (160 kD). Several smaller bands are also recognized
by the antibody, but it only depletes the 160 kD band, suggest-
ing that ICIS is the only protein that is recognized in the native
conformation. The antibody against the ICIS D region was
added to a microtubule depolymerase reaction, and the anti-
body blocked the reactivation of Kif2a by ICIS D (Figure 2A).
To determine the importance of the C terminus of ICIS in
cultured cells, we injected this antibody into prophase Xeno-
pus S3 cells stably expressing GFP-tubulin (Figure 2B and
Movie S1). Whereas control IgG-injected cells assemble
bipolar spindles by 6–10 min (Figure 2B) and complete
anaphase by 45 min, a-ICIS-injected cells (n = 8) form mono-
polar spindles and maintain a mitotic arrest for at least 70 min
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B Figure 1. ICIS Reverses Aurora Inhibition of Kif2a
In Vitro
(A) Titration of Kif2a into a visual MT depolymer-
ase assay demonstrates depolymerase activity
is concentration dependent at 3 min. Error bars
represent SD.
(B) Map of Xenopus ICIS showing the different
truncation proteins that were cloned and bacteri-
ally expressed.
(C) ICIS D reactivates Kif2a that has been in-
hibited by Aurora kinase. Schematic of the
in vitro depolymerase assay and quantification
of the mean number of microtubules per field in
the presence of recombinant Kif2a, Aurora B,
and the C-terminal fragment of ICIS (ICIS D). Error
bars represent SD.
(D) Depolymerase assays titrating the amount of
ICIS D added after prephosphorylation of Kif2a
with Aurora B. Relative Kif2a activity was calcu-
lated with Kif2a alone as 100% activity and
Kif2a + Aurora B as 0% activity. Error bars repre-
sent SD.
(E) ICIS does not reactivate by dephosphorylating
Kif2a. Immunoblot of a-pS132 Kif2a in an in vitro
depolymerase reaction as in (C).
(F) Immunoblots showing that ICIS D interacts
with Kif2a, MCAK, Aurora B, INCENP, and TD-60
in Xenopus mitotic extracts. ICIS D or 6His-GST
was covalently attached to beads and incubated
in mitotic extract, and the washed beads were
probed for the indicated proteins.
(G) ICIS D interacts directly with Kif2a in vitro. Re-
combinant S-tagged-Kif2a was incubated with
the beads used in (F), and bound Kif2a was de-
tected with S-protein-HRP. Input represents
20% of the reaction.
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760(Movie S2). This result phenocopies siRNA knockdown of Kif2a
in U2OS cells [8], although there is no evidence to support
Kif2a’s role in bipolarity in Xenopus cells. The injected anti-
bodies primarily localize to spindle poles (Figure S7). We
note that the requirement for ICIS D may not be universal,
given that this monopolar spindle phenotype could not be
recapitulated in Xenopus extracts (data not shown). Because
an antibody that blocks the reactivation activity of ICIS
also generates spindle defects, these data argue that ICIS re-
activation of kinesin-13 s is required for proper spindle
function.
Monopolar Spindles Generated by a-ICIS Injection
Are Rescued by Coinjecting a-Nuf2
Monopolar spindles can be generated by defects in centro-
some separation, regulators of microtubule dynamics (Kif2a
and Aurora A), or inhibition of kinesins that crosslink pole-to-
pole microtubules (Eg-5 and KSP-1). In the a-ICIS-injected
cells, we see separation of poles before nuclear envelope
breakdown, arguing for proper centrosome segregation.
Previous experiments have shown that inhibition of a class
of proteins that regulate K fiber dynamics can be rescued by
coinhibition of kinetochore-microtubule binding, whereas mo-
nopolarity generated by Eg-5 inhibition is not rescued by this
treatment [8]. To classify the monopolarity generated by anti-
ICIS injection, we coinjected a-Nuf2 antibodies along with
a-ICIS D antibodies into GFP-tubulin-expressing S3 cells (n = 6)
(Figure 3 and Movie S3). We found that coinjection did indeed
rescue spindle bipolarity, and the cells proceeded through
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Figure 2. Injection of a-ICIS Antibodies into Cells
Gives a Monopolar Spindle Phenotype
(A) ICIS D antibodies inhibit Kif2a reactivation
in vitro. Quantification of the mean number of
microtubules per field in the presence of re-
combinant Kif2a, Aurora B, ICIS D, and a-ICIS.
Error bars represent SD.
(B) IgG control injected and a-ICIS injected in
prophase Xenopus S3 cells expressing GFP-
tubulin. Time lapse images from Movies S1 and
S2. 0 min = time of injection. Scale bar represents
10 mm.
mitosis with a ‘‘cut’’ phenotype, which
is expected in a cell with defective kinet-
ochores. These data suggest that
knocking out the kinesin-13 reactivating
function of ICIS in Xenopus cells may
generate monopolarity through a similar
pathway as siRNA knockdown of Kif2a
in U2OS cells.
Kif2a Is Localized to Centromeres
in Xenopus Cells
ICIS and MCAK are localized to both
centromeres and spindle poles in Xeno-
pus [7, 9, 10]. In human U2OS cells, Kif2a
localizes to spindle poles during mitosis
and Kif2b localizes to centromeres [11].
Xenopus appears to only have a gene
for Kif2a. We generated a polyclonal
antibody against Kif2a to determine its
localization in Xenopus cells. The Kif2a
antibody recognized a single band
around 85 kD, the expected size in Xenopus (Figure S8A).
When the antibody was used for immunofluorescence in
Xenopus cells, it labeled spindle poles throughout mitosis
(Figure S8B, arrows). Kif2a is also localized to most centro-
meres during prometaphase and to a smaller number of centro-
meres at metaphase (Figure S8B, inset). Thus, Kif2a, MCAK,
and ICIS concentrate at the same cellular locations in Xenopus
cells.
ICIS Interacts with Aurora B Kinase, Its Substrates,
and Its Activators
ICIS binds microtubules and coimmunoprecipitates with
members of the chromosomal passenger complex (CPC) and
MCAK [7]. We mapped these interactions by covalently attach-
ing the four ICIS fragments to Sepharose beads, incubating
them in a Xenopus CSF-arrested extract and probing the inter-
acting proteins by immunoblot (Figure 4A). We found that the
N terminus of ICIS (ICIS A) interacts with Aurora B and with
its activators INCENP and TD-60 [12]. A middle region (ICIS B
fragment) interacts with both Kif2a and MCAK (Figure 4A).
These data show that ICIS interacts with Aurora B kinase, its
activators, and two substrates, Kif2a and MCAK.
To determine which domain of ICIS is responsible for micro-
tubule binding, we added taxol to Xenopus M phase extracts
and pelleted microtubules and their interacting proteins
through sucrose cushions. Microtubules pelleted ICIS B and
ICIS C (Figure 4B). ICIS C also bound purified taxol-stabilized
microtubules; however, ICIS B did not, and there was a weak
interaction with ICIS D. (Figure 4B0).
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761We visualized complexes of ICIS C and purified rhodamine-
labeled microtubules by fluorescence microscopy. ICIS C
bundled microtubules (Figure 4C). The bundles appear to be
aggregations of laterally associated microtubules, and the
bundles are longer than the individual microtubules used in
the assay. The other fragments of ICIS did not bundle microtu-
bules.
Previous to this study, it was not understood why microtu-
bule depolymerases would be phosphorylated on inhibitory
sites in cellular locations where their activity is required [1, 3,
6]. This work reveals a novel form of regulation of these kine-
sins, whereby phosphorylated and inhibited depolymerases
can be reactivated by ICIS without being dephosphorylated
(Figure 4D). It remains to be seen whether phosphatase activity
also plays a role in the reactivation of kinesin-13 family mem-
bers. Our structure function analysis of ICIS implicates it as
a potential scaffold, which could bring together the activator
and the inhibitors of kinesin-13 depolymerases (Figure 4D) to
facilitate tight spatial and temporal regulation of depolymerase
activity in the mitotic spindle.
Experimental Procedures
Protein Expression and Antibody Production
The full-length Xenopus laevis ICIS cDNA clone was obtained from R. Ohi
(Vanderbilt University, Nashville, TN). A series of bacterial expression
constructs were generated by PCR and subcloned into pET30 with 50 Nco
I and 30 Not I overhangs. The following primers were used to clone the
different fragments of ICIS into pET30: for ICIS A (ICIS1–334), 50-CGCGGATC
CATGGGATGAGTGTGCAAACAGCAACT-30 and 50-TCGAGTGCGGCCGCC
TACACTTCTAGCATCACTTCACT-30; for ICIS B (ICIS334–724), 50-CGCGGATC
CATGGGGGTGGATGCTCGTAGGGTGATG-30 and 50-TCGAGTGCGGCCGC
CTAATCTGCAGATACAGTGCCTTC-30; for ICIS C (ICIS724–992), 50-CGCGGA
TCCATGGGGGATATGGATATCTTGGCCAAC-30 and 50-TCGAGTGCGGCC
GCCTAGTTACTGCTGCTGAGGAGAT-30; and for ICIS D (ICIS992–1338), 50-CG
CGGATCCATGGGGAACCAAAGGTTCGAGGCACTG-30 and 50-TCGAGTGC
GGCCGCTCATCTGGGAGACACCGTCGG-30.
GST-tagged ICIS fragments were cloned by digesting pET30 constructs
with NcoI/NotI and replacing the inserts into pGEX-4TS3.
ICIS fragments were expressed in the E. coli strain BL21 (DE3 pLysS,
Novagen). All 6His-tagged proteins were purified on Ni2+-NTA agarose as
instructed by the manufacturer (QIAGEN, Chatsworth, CA). Glutathione
S-transferase (GST)-tagged proteins were purified on glutathione agarose
beads. Purified proteins were covalently coupled to CNBr-activated Se-
pharose beads according to the manufacturer’s instructions (Amersham
Biosciences, Piscataway, NJ).
Antibodies were produced from the 6His-ICIS D recombinant protein by
Covance Research Products (Denver, PA). Antibodies raised against 6His-
tagged proteins were purified over corresponding GST-tagged protein
columns and vice versa. Affinity-purified antibodies were dialyzed into PBS.
The cDNA clone of human Kif2a (BC033842) was purchased from Open
Biosystems (Huntsville, AL). Kif2a aa 530–679 was cloned into pET30a by
using primers with the sequences 50-GCGGATCCCGGATGCCAACTGCTG
CTGGTG-30 and 50-GATCGGAATTCGTTAAAGGGCACGGGGTCTCTT-30 to
generate the construct Pet30a-Kif2a (530–679). Recombinant protein was
expressed in (pLysS) BL21 bacteria for 4 hr at room temperature. This
6His-tagged protein was purified with conventional nickel bead affinity (Qai-
gen) according to the manufacturer’s instructions, and the protein was used
to make a polyclonal rabbit antibody (Covance, Denver, PA).
Kif2a minimal domain (aa 118–530) was cloned into pET30a as well by
using primers with the sequences 50-GCGGATCCCGGATGGCAAAAAAGG
AATTTGG and 50-GATCGCGGCCGCTTATGGATCTACAGTCAATTCTTT-30
and was expressed and purified as above. The protein was dialyzed into
supplemented kinase buffer (20 mM tris [pH 7.5], 1 mM MgCl2, 25 mM
KCl, 50 mM NaCl, 1 mM DTT, and 5% glycerol).
The pS132 antibody was raised against the peptide C-GPPSRRKpSN
(synthesized in Yale’s W.M. Keck Protein Core facility, New Haven, CT).
The peptide was attached to KLH with SMCC (Pierce), and the resulting
conjugate was injected into rabbits to produce polyclonal serum (Covance).
For affinity purification, both phospho and nonphospho columns were
generated with Sulfo-beads (Pierce) according to the manufacturer’s
instructions. Antibodies were affinity purified first by counterselection on
the nonphosphopeptide before being affinity purified on the phosphopep-
tide column [13]. Immunoblots were performed as previously described
[14], with the exception that, with phosphopeptide antibodies, the PVDF
membrane was blocked in 3% BSA.
Visual Microtubule Depolymerase Assays
Microtubule depolymerase assays for Kif2a were performed as described
for MCAK [1] with 50 nM Kif2a minimal domain, 50 nM ICIS fragments
(unless otherwise noted), and 1 nM Aurora B/INCENP in the assays. In brief,
the proteins were incubated with microtubules in CSF-XB (10 mM K-HEPES
Figure 3. a-ICIS Injection Phenotype Can Be Rescued by Coinjection with a-Nuf2
S3 cells expressing GFP-tubulin were coinjected with a-ICIS and a-Nuf2 antibodies and filmed, and spindle morphology was observed. The coinjected cells
had a restored bipolar spindle phenotype. Images are stills from Movie S3. Scale bar represents 10 mm.
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762[pH 7.7], 100 mM KCl, 2 mM MgCl2, 0.1 CaCl2, 50 mM sucrose, and 5 mM
EGTA), with 2 mM ATP, 1 mM DTT, and 15 mM taxol. At the time points indi-
cated, 1 ul samples were taken, diluted into 5 ul fix solution, and spotted
onto a slide. Four fields were taken per time point with a 1003 objective.
The images were acquired as above and analyzed with Metavue software.
Microtubule Pelleting Assays
For microtubule pelleting in CSF extracts, we treated fresh extracts with
either 10 mM Taxol or 10 mg/ml Nocodazole (negative control) for 30 min at
room temperature. Microtubules and associated proteins were spun
through 1 M sucrose cushion. For microtubule pelleting in vitro, we incu-
bated preformed taxol-stabilized pure microtubules (Cytoskeleton, Denver,
CO) with different ICIS mutants at room temperature for 30 min. The reaction
mixtures were pelleted through 1 M sucrose cushion, washed, and detected
by S-protein-HRP or a-tubulin antibody.
Cell Injections
Xenopus laevis S3 cells stably transfected with a-tubulin-GFP were used for
microinjections. Cells were kept at 23C in 70% Leibovitz’s L-15 medium con-
taining 15% FBS, L-Glutamine, and penicillin-streptomycin. For microscopy,
cells were grown on glass coverslips. Cells were injected with the following
antibodies diluted in PBS: rabbit polyclonal anti-ICIS C terminus at a needle
concentration of 9mg/ml and anti-xNuf2 ata needle concentrationof 4 mg/ml.
Anti-xNuf2 antibodies were characterized previously [15]. Control cells were
Figure 4. Mapping Where Proteins Bind ICIS
(A) Mapping domains of ICIS interactions. The
specified recombinant fragments of ICIS were
purified from E. coli, covalently attached to
beads, and incubated in a mitotic extract. Bound
proteins were eluted, and immunoblots were per-
formed on eluates.
(B) Microtubule pelleting assays were performed
by adding ICIS fragments and taxol to mitotic
extracts, pelleting microtubules, and detecting
ICIS by S-protein-HRP (B) or by measuring the
affinity of ICIS fragments to purified taxol-stabi-
lized microtubules (B0).
(C) ICIS C bundles microtubules in vitro. Rhoda-
mine-labeled microtubules were incubated with
ICIS C and visualized by fluorescent microscopy.
Fields taken with a 1003 objective are shown,
and magnified views are shown to the right. Scale
bar represents 10 mm.
(D) Model showing ICIS as a potential scaffold
that brings together Kinesin-13 s with its acti-
vator (ICIS) and its inhibitor CPC. ICIS also brings
Aurora B into contact with its activators TD-60
and microtubules.
injected with nonspecific rabbit IgG at a needle
concentration of 4 mg/ml. All injections were
done before nuclear envelope breakdown (NEB).
The cells were analyzed with a Zeiss Axiovert
200 M microscope equipped with Planapochro-
mat 633 (N.A. 1.4) and 1003 (N.A. 1.4) objectives
and a Hamamatsu Orca ER CCD camera (Hama-
matsu Photonics). Images were captured with
Metamorph software (Molecular Devices).
Supplemental Data
Supplemental Data include eight figures and
three movies and can be found with this article
online at http://www.cell.com/current-biology/
supplemental/S0960-9822(09)00821-5.
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